FENC FY 2023 Earnings — Fennec Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

FENCFennec Pharmaceuticals Inc.

$220M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21M+1341.6% YoY

Gross Profit

$20M94.1% margin

Operating Income

-$13M-60.1% margin

Net Income

-$16M-75.5% margin

EPS (Diluted)

$-0.60

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$27M

Total Liabilities

$38M

Stockholders' Equity

-$12M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$1M	+1341.6%
Gross Profit	$20M	$1M	+1336.7%
Operating Income	-$13M	-$22M	+41.1%
Net Income	-$16M	-$23M	+29.5%